The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Highly cytotoxic EGFR/CD16A TandAbs to recruit NK-cells to kill EGFR-expressing tumor cells.
 
Martin Treder
Employment - Affimed Therapeutics
Leadership - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
Patents, Royalties, Other Intellectual Property - Affimed Therapeutics
 
Kristina Ellwanger
Employment - Affimed Therapeutics
 
Uwe Reusch
Employment - Affimed Therapeutics
Patents, Royalties, Other Intellectual Property - Affimed Therapeutics (Inst)
 
Ivica Fucek
Employment - Affimed Therapeutics
 
Michael Weichel
Employment - Affimed Therapeutics
 
Thorsten Gantke
Employment - Affimed Therapeutics
 
Stefan Knackmuss
Employment - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Oscar Kashala
Leadership - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Jens-Peter Marschner
Employment - Affimed Therapeutics
Leadership - Affimed Therapeutics
Stock and Other Ownership Interests - Affimed Therapeutics
 
Xing Zhao
No Relationships to Disclose
 
Narendiran Rajasekaran
No Relationships to Disclose
 
Holbrook Edwin Kohrt
Consulting or Advisory Role - Affimed Therapeutics
Research Funding - Affimed Therapeutics (Inst)
Travel, Accommodations, Expenses - Affimed Therapeutics